Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/mds.28170 http://scihub22266oqcxt.onion/10.1002/mds.28170 32449528!7280741!32449528     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Mov+Disord 2020 ; 35 (8): 1287-1292 Nephropedia Template TP {{tp|p=32449528|t=2020. Effects of COVID-19 on Parkinson s Disease Clinical Features: A Community-Based Case-Control Study |pdf=|usr=}}{{32449528}} gab.com Text Effects of COVID-19 on Parkinson s Disease Clinical Features: A Community-Based Case-Control Study JO: Mov Disord http://www.kidney.de/pget.php?&tw=1&pmid=32449528 #FOAvip The impact of coronavirus disease 2019 (COVID-19) on clinical features of Parkinson's disease (PD) has been poorly characterized so far. Of 141 PD patients resident in Lombardy, we found 12 COVID-19 cases (8.5%), whose mean age and disease duration (65.5 and 6.3 years, respectively) were similar to controls. Changes in clinical features in the period January 2020 to April 2020 were compared with those of 36 PD controls matched for sex, age, and disease duration using the clinical impression of severity index for PD, the Movement Disorders Society Unified PD Rating Scale Parts II and IV, and the nonmotor symptoms scale. Motor and nonmotor symptoms significantly worsened in the COVID-19 group, requiring therapy adjustment in one third of cases. Clinical deterioration was explained by both infection-related mechanisms and impaired pharmacokinetics of dopaminergic therapy. Urinary issues and fatigue were the most prominent nonmotor issues. Cognitive functions were marginally involved, whereas none experienced autonomic failure. (c) 2020 International Parkinson and Movement Disorder Society. Twit Text FOAVip Effects of COVID-19 on Parkinson s Disease Clinical Features: A Community-Based Case-Control Study ????Mov Disord http://www.kidney.de/pget.php?&tw=1&pmid=32449528 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32449528 #FOAvip English Wikipedia <ref>{{Cite pmid|32449528}}</ref> Effects of COVID-19 on Parkinson s Disease Clinical Features: A Community-Based Case-Control Study #MMPMID32449528 Cilia R; Bonvegna S; Straccia G; Andreasi NG; Elia AE; Romito LM; Devigili G; Cereda E; Eleopra R Mov Disord 2020[Aug]; 35 (8): 1287-1292 PMID32449528show ga The impact of coronavirus disease 2019 (COVID-19) on clinical features of Parkinson's disease (PD) has been poorly characterized so far. Of 141 PD patients resident in Lombardy, we found 12 COVID-19 cases (8.5%), whose mean age and disease duration (65.5 and 6.3 years, respectively) were similar to controls. Changes in clinical features in the period January 2020 to April 2020 were compared with those of 36 PD controls matched for sex, age, and disease duration using the clinical impression of severity index for PD, the Movement Disorders Society Unified PD Rating Scale Parts II and IV, and the nonmotor symptoms scale. Motor and nonmotor symptoms significantly worsened in the COVID-19 group, requiring therapy adjustment in one third of cases. Clinical deterioration was explained by both infection-related mechanisms and impaired pharmacokinetics of dopaminergic therapy. Urinary issues and fatigue were the most prominent nonmotor issues. Cognitive functions were marginally involved, whereas none experienced autonomic failure. (c) 2020 International Parkinson and Movement Disorder Society. |Betacoronavirus/*pathogenicity[MESH] |COVID-19[MESH] |Case-Control Studies[MESH] |Cognition Disorders/virology[MESH] |Cognition/physiology[MESH] |Coronavirus Infections/*complications/*virology[MESH] |Depression/psychology/virology[MESH] |Humans[MESH] |Pandemics[MESH] |Parkinson Disease/complications/*physiopathology/virology[MESH] |Pneumonia, Viral/*complications/*virology[MESH]Effects of COVID-19 on Parkinson s Disease Clinical Features: A Commun(epmc).pdf DeepDyve Pubget Overpricing